9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease
ConditionUrethral Stricture
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-100
SponsorUniversity Hospital, Ghent
About this trial
It has been demonstrated that urethroplasty should be considered the gold standard treatment for urethral stricture disease as it yields higher long-term success rates than endoscopic treatment options such as direct vision internal urethrotomy (DVIU) or dilation. Many data about these procedures exist, although most of the publications about urethroplasty are retrospective and involve a tremendous risk of bias. To address these issues, this study is designed to prospectively gain evidence about this matter in all patient subgroups facing a potential treatment with urethroplasty: native men, native women, transmen, transwomen and children.
Eligibility criteria
Qualifiers
Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations.
Patient age ≥ 6 years.
If a patient reaches the age of 18 years, he or she will have to provide a new voluntarily signed written informed consent. All patients reaching the age of 18 years will be contacted by the Principal Investigator or Subinvestigator to provide a new voluntarily signed written informed consent.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Urethroplasty
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov